FAP and neoplasm: Because of the consistent presence of FAP on the tumor stroma and the accessibility of FAP-positive tumor stromal fibroblasts to circulating monoclonal antibodies (mAbs), several studies have suggested possible diagnostic and therapeutic applications of humanized mAb and their constructs with novel immune and nonimmune effector functions.